Spirochetemia due to Treponema pallidum using polymerase-chain-reaction assays in patients with early syphilis: Prevalence, associated factors and treatment response

Clinical Microbiology and Infection

Volumn 20, Issue 8, 2014, Pages

  Wu, B R ^a   Tsai, M S ^b   Yang, C J ^b   Sun, H Y ^c   Liu, W C ^c   Yang, S P ^c   Wu, P Y ^c   Su, Y C ^c   Chang, S Y ^a,c   Hung, C C ^c,d,e  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Azithromycin; Molecular diagnosis; Penicillin; Sexually transmitted infection; Spirochete

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACTERIAL DNA;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIMARY SYPHILIS; PRIORITY JOURNAL; SECONDARY SYPHILIS; SPIROCHETE INFECTION; SPIROCHETEMIA; SYPHILIS; TREATMENT RESPONSE; TREPONEMA PALLIDUM; TREPONEMATOSIS; BACTEREMIA; BLOOD; ISOLATION AND PURIFICATION; PREVALENCE;

SPIROCHAETALES; TREPONEMA PALLIDUM;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CD4 LYMPHOCYTE COUNT; DNA, BACTERIAL; FEMALE; HUMANS; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; SYPHILIS; TREPONEMA PALLIDUM;

EID: 84906790619     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12504     Document Type: Article

References (14)

1. Workowski KA, Berman S; Centers for Disease Control, Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010; 59: 1-110.
2. Grimprel E, Sanchez PJ, Wendel GD et al. Use of polymerase chain reaction and rabbit infectivity testing to detect Treponema pallidum in amniotic fluid, fetal and neonatal sera, and cerebrospinal fluid. J Clin Microbiol 1991; 29: 1711-1718.
3. Sanchez PJ, Wendel GD Jr, Grimprel E et al. Evaluation of molecular methodologies and rabbit infectivity testing for the diagnosis of congenital syphilis and neonatal central nervous system invasion by Treponema pallidum. J Infect Dis 1993; 167: 148-157.
4. Liu H, Rodes B, Chen CY, Steiner B. New tests for syphilis: rational design of a PCR method for detection of Treponema pallidum in clinical specimens using unique regions of the DNA polymerase I gene. J Clin Microbiol 2001; 39: 1941-1946.
5. Lukehart SA, Godornes C, Molini BJ et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004; 351: 154-158.
6. Grange PA, Gressier L, Dion PL et al. Evaluation of a PCR test for detection of Treponema pallidum in swabs and blood. J Clin Microbiol 2012; 50: 546-552.
7. Matejkova P, Flasarova M, Zakoucka H et al. Macrolide treatment failure in a case of secondary syphilis: a novel a2059 g mutation in the 23s rRNA gene of Treponema pallidum subsp. pallidum. J Med Microbiol 2009; 58: 832-836.
8. Pillay A, Liu H, Chen CY et al. Molecular subtyping of Treponema pallidum subspecies pallidum. Sex Transm Dis 1998; 25: 408-414.
9. Marra C, Sahi S, Tantalo L et al. Enhanced molecular typing of Treponema pallidum: geographical distribution of strain types and association with neurosyphilis. J Infect Dis 2010; 202: 1380-1388.
10. Carlson JA, Dabiri G, Cribier B, Sell S. The immunopathobiology of syphilis: the manifestations and course of syphilis are determined by the level of delayed-type hypersensitivity. Am J Dermatopathol 2011; 33: 433-460.
11. Leader BT, Godornes C, VanVoorhis WC, Lukehart SA. Cd4+ lymphocytes and gamma interferon predominate in local immune responses in early experimental syphilis. Infect Immun 2007; 75: 3021-3026.
12. Lafond RE, Lukehart SA. Biological basis for syphilis. Clin Microbiol Rev 2006; 19: 29-49.
13. Li J, Wang LN, Zheng HY. Predictors of serological cure and serofast state after treatment in hiv-negative patients with early syphilis in China. Sex Transm Infect 2013; 89: 69.
14. Tong ML, Lin LR, Liu GL et al. Factors associated with serological cure and the serofast state of hiv-negative patients with primary, secondary, latent, and tertiary syphilis. PLoS ONE 2013; 8: e70102.